No CrossRef data available.
Article contents
Quantification of Ki67 Staining Density in Tumors of the Colon Using Automated Slide Scanning Followed by Analysis Using the DensitoQuant Module in Quant Center
Published online by Cambridge University Press: 30 July 2020
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Biomedical and Pharmaceutical Research on the Development, Diagnosis, Prevention, and Treatment of Diseases
- Information
- Copyright
- Copyright © Microscopy Society of America 2020
References
Leung, S., Nielsen, T., Zabaglo, L. et al. Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration. npj Breast Cancer 2, 16014 (2016). https://doi.org/10.1038/npjbcancer.2016.14Google Scholar
Augustine, T., Maitra, R., Zhang, J. et al. Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparib. Invest New Drugs, (2019). 37: 948. https://doi.org/10.1007/s10637-018-00717-9CrossRefGoogle ScholarPubMed
Brown, D.C.. and Gatter, K.C.. Ki67 protein: the immaculate deception?. Histopathology, 40: 2–11 (2002). https://doi:10.1046/j.1365-2559.2002.01343.xCrossRefGoogle ScholarPubMed
All imaging was conducted in the Analytical Imaging Facility (AIF) (funded by NCI Cancer Grant P30CA013330). Imaging was conducted on a HISTECH P250 High Capacity Slide Scanner funded by SIG (#1S10OD019961-01). The authors would also like to thank Frank Macaluso for proofreading the manuscript.Google Scholar
You have
Access